HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
4-Bromo-6-(4-methyl-1-piperazinyl)-9-methyl-1,2-dihydrobenzo[b]-pyrrolo [3,2,1-jk][1,4]benzodiazepine → 4-Bromo-6-(4-methyl-1-piperazinyl)-9-methylbenzo[b]pyrrolo-[3,2,1-jk][1,4]benzodiazepine
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 4-Bromo-6-(4-methyl-1-piperazinyl)-9-methyl-1,2-dihydrobenzo[b]-pyrrolo [3,2,1-jk][1,4]benzodiazepine | HCID 13823314 | — |
| Katalysator | HCID 178418406 | HCID 178418406 | — |
| Lösungsmittel | Chloroform | HCID 6212 | — |
| Produkt | 4-Bromo-6-(4-methyl-1-piperazinyl)-9-methylbenzo[b]pyrrolo-[3,2,1-jk][1,4]benzodiazepine | HCID 13823308 | — |
Reaktionsschritte
To a solution of 4-bromo-6-(4-methyl-1-piperazinyl)-9 -methyl-1,2-dihydrobenzo[b]pyrrolo[3,2,1-jk][1,4]benzodiazepine (5.7 g, 13.8 mmoles) in chloroform (540 ml) was added manganese dioxide (25 gm), and the mixture was heated under reflux for 40 days. The mixture was filtered, and the filter cake washed with dichloromethane. The filtrate was concentrated under vacuum.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US04764616 |
| Quelldatensatz | uspto-grants-1988_08 |
| ORD ID | ord-61b91ee252014689baa77b43a53f2a41 |
| Quellennotiz | uspto-grants-1988_08 |